Michael F La Fountaine Selected Research

Michael F La Fountaine Research Topics

16	Spinal Cord Injuries (Spinal Cord Injury) 08/2020 - 01/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 07/2015
3	Insulin Resistance 07/2021 - 07/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018
1	Craniocerebral Trauma (Head Injury) 01/2016
1	Quadriplegia (Spastic Quadriplegia) 01/2009

6	Triglycerides (Triacylglycerol)IBA 07/2021 - 01/2017
4	Testosterone (Sustanon)FDA Link 01/2015 - 01/2011
3	LipidsIBA 07/2021 - 07/2015
3	HDL CholesterolIBA 07/2021 - 07/2015
3	Lipoproteins (Lipoprotein)IBA 01/2020 - 07/2015
3	Insulin (Novolin)FDA Link 01/2017 - 02/2013
2	Fenofibrate (CiL)FDA LinkGeneric 01/2020 - 11/2019
2	HDL LipoproteinsIBA 11/2018 - 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 07/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Denosumab FDA Link 08/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	LDL CholesterolIBA 07/2015
1	oxidized low density lipoproteinIBA 07/2015
1	Zoledronic Acid (Zometa)FDA Link 07/2015
1	Baclofen FDA LinkGeneric 09/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2009

4	Therapeutics 01/2020 - 01/2013